NCT07686315 Advanced Respiratory Monitoring for Safer Mechanical Ventilation in Patients Without Respiratory Failure
| NCT ID | NCT07686315 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Clinico Humanitas |
| Condition | Developing Acute Respiratory Distress Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-06-30 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-06-30 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients admitted to the intensive care unit (ICU) and mechanically ventilated for reasons other than acute respiratory failure, such as coma, trauma, or sepsis, are at risk of developing acute respiratory distress syndrome (ARDS), which increases the duration of mechanical ventilation, mortality, and functional dependence at discharge.
Eligibility Criteria
Study Population Eligibility Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Inclusion Criteria: Adult patients +18 years. Undergoing invasive mechanical ventilation for reasons other than acute respiratory failure (such as coma, trauma, or sepsis). Initiation of monitoring within 24 hours of oro-tracheal intubation. Exclusion Criteria: Evidence of pneumothorax, pneumomediastinum, or subcutaneous emphysema. Pregnancy. Absolute contraindications to nasogastric tube placement. Absolute contraindications to electrical impedance tomography (EIT) monitoring.
Frequently Asked Questions
Who can join the NCT07686315 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Developing Acute Respiratory Distress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07686315 currently recruiting?
Yes, NCT07686315 is actively recruiting participants. Visit ClinicalTrials.gov or contact Istituto Clinico Humanitas to inquire about joining.
Where is the NCT07686315 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT07686315 clinical trial?
NCT07686315 is sponsored by Istituto Clinico Humanitas. The trial plans to enroll 40 participants.